omega-n-methylarginine has been researched along with 6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2h-pyran-2-one in 1 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2h-pyran-2-one) | Trials (6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2h-pyran-2-one) | Recent Studies (post-2010) (6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2h-pyran-2-one) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 195 | 0 | 30 |
| Protein | Taxonomy | omega-n-methylarginine (IC50) | 6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2h-pyran-2-one (IC50) |
|---|---|---|---|
| Fatty-acid amide hydrolase 1 | Homo sapiens (human) | 0.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bohrer, A; Hsu, FF; Ma, Z; Ramanadham, S; Turk, J | 1 |
1 other study(ies) available for omega-n-methylarginine and 6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2h-pyran-2-one
| Article | Year |
|---|---|
Studies of the role of group VI phospholipase A2 in fatty acid incorporation, phospholipid remodeling, lysophosphatidylcholine generation, and secretagogue-induced arachidonic acid release in pancreatic islets and insulinoma cells.
Topics: Animals; Arachidonic Acid; Cricetinae; Enzyme Inhibitors; Ethylmaleimide; Fatty Acids; Group VI Phospholipases A2; Insulinoma; Interleukin-1; Islets of Langerhans; Lysophosphatidylcholines; Male; Naphthalenes; omega-N-Methylarginine; Phosphodiesterase Inhibitors; Phospholipases A; Phospholipases A2; Phospholipids; Propranolol; Pyrones; Rats; Rats, Sprague-Dawley; Tumor Cells, Cultured | 1999 |